
    
      A cohort of subjects with asthma and healthy controls will be exposed to inhaled mannitol
      according to FDA approved protocols for bronchoprovocation. Mannitol will be measured in the
      bloodstream and urine and used to determine an airway permeability index. This is a proof of
      concept study and not a trial of new therapeutics.
    
  